Check-Cap falls after downbeat Q4 earnings

Mbody Ai

07/04/2022 18:04

** U.S.-listed shares of Israel-based biotech firm  CHEK.O 
fall ~4.7% at $0.36 in afternoon trade 
    ** Co's net loss in Q4 widens to $5.5 mln vs $3.9 mln a year
earlier, weighed down by higher expenses 
    ** CHEK says bigger loss primarily due to a jump in its
employee headcount adding to salary and compensation costs 
    ** Research and development expenses in Q4 were $4.1 mln vs
$2.8 mln last year  
    ** Including session's loss, shares down ~45.9% YTD 

 (Reporting by Manya Saini in Bengaluru)
 ((Manya.Saini@thomsonreuters.com;))